Fecal Calprotectin Testing - (0121) — MM 0121 | CIGNA Coverage Update

Cigna modified MM 0121 for fecal calprotectin testing (CPT 83993), effective September 26, 2025. Here's what billing teams need to know.

Cigna Healthcare updated its coverage policy for fecal calprotectin testing under policy code MM 0121, with an effective date of September 26, 2025. This update governs CPT 83993 — the code your lab or GI practice bills for fecal calprotectin — and ties coverage to a specific set of IBD-related diagnoses spanning 84 ICD-10-CM codes. If your team bills CPT 83993 for Crohn's disease, ulcerative colitis, or irritable bowel syndrome workups, this policy change directly affects your claim outcomes.

Quick-Reference Table

Cigna Fecal Calprotectin Coverage Criteria and Medical Necessity Requirements 2025

The core of this Cigna fecal calprotectin coverage policy is straightforward: CPT 83993 is medically necessary when the patient's diagnosis maps to the covered ICD-10-CM codes listed in MM 0121. The policy covers Crohn's disease (K50.xx), ulcerative colitis (K51.xx), and irritable bowel syndrome (K58.xx) diagnoses, among others.

The real issue here is specificity. Cigna maps 84 ICD-10-CM codes to this single CPT code, covering every complication variant for both Crohn's and ulcerative colitis. That granularity matters. A claim billed with K50.90 (Crohn's disease, unspecified, without complications) sits in a different coding position than K50.014 (Crohn's disease of small intestine with abscess). Both may meet medical necessity — but only if your documentation supports the specificity of the code you choose.

Cigna's medical necessity standard for CPT 83993 requires the clinical indication to match the covered diagnosis list. Billing a calprotectin test with a non-covered diagnosis — say, a vague abdominal pain code that isn't on the approved list — will produce a claim denial. This is a common failure point when ordering physicians don't document IBD workup intent clearly.

The policy addresses fecal calprotectin testing in two clinical contexts: initial diagnosis evaluation and ongoing management of established IBD. Whether Cigna treats these identically or applies different criteria to each isn't fully spelled out in the policy summary. If your practice bills CPT 83993 for disease monitoring in known IBD patients, verify with your Cigna provider rep or check the full policy text at the source before September 26, 2025.

Prior authorization requirements for CPT 83993 under MM 0121 aren't explicitly detailed in the policy summary. That said, prior auth requirements can vary by Cigna plan. Check the specific plan type for each patient — commercial, Cigna+ Spree, or employer-sponsored plans can have different rules layered on top of the base coverage policy.

Cigna Fecal Calprotectin Exclusions and Non-Covered Indications

The policy summary doesn't enumerate explicit non-covered indications in the data provided. That's worth noting because it cuts both ways.

The absence of a stated exclusion list doesn't mean everything is covered. Cigna's standard medical necessity framework applies: if the diagnosis doesn't appear in the covered ICD-10-CM code set, the claim is not covered under MM 0121. A claim billed with a diagnosis outside the 84-code list won't get covered just because nothing explicitly excludes it.

Watch for IBS coding in particular. The policy includes K58.0 (irritable bowel syndrome with diarrhea) and K58.1 (irritable bowel syndrome with constipation) in the covered set. That's meaningful — calprotectin is often ordered to differentiate IBD from IBS. But if the working diagnosis is documented as IBS and the test comes back normal, verify whether continued testing under an IBS code still meets Cigna's medical necessity standard for subsequent claims.

Coverage Indications at a Glance

Cigna Fecal Calprotectin Billing Guidelines and Action Items 2025

These are the steps your billing team should take before and after September 26, 2025.

If your practice has high calprotectin testing volume and you're uncertain how this policy change interacts with your specific Cigna contract terms, talk to your billing consultant or compliance officer before the effective date.

CPT, HCPCS, and ICD-10 Codes for Fecal Calprotectin Testing Under MM 0121

Covered CPT Codes (When Medical Necessity Criteria Are Met)

Key ICD-10-CM Diagnosis Codes

The policy data references four additional ICD-10-CM codes not fully detailed in the available summary. Pull the complete code list from the full MM 0121 policy document at Cigna's provider portal before September 26, 2025.